Concourse Financial Group Securities, Inc. Aurinia Pharmaceuticals Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
29 transactions
Others Institutions Holding AUPH
# of Institutions
254Shares Held
61.3MCall Options Held
1.03MPut Options Held
666K-
Tang Capital Management LLC San Diego, CA10MShares$147 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$135 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$58 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$40.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$35 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.07B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...